These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 18177349)
21. Serotonin and GI clinical disorders. Spiller R Neuropharmacology; 2008 Nov; 55(6):1072-80. PubMed ID: 18687345 [TBL] [Abstract][Full Text] [Related]
22. The role of serotonin in intestinal luminal sensing and secretion. Hansen MB; Witte AB Acta Physiol (Oxf); 2008 Aug; 193(4):311-23. PubMed ID: 18462271 [TBL] [Abstract][Full Text] [Related]
23. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499 [TBL] [Abstract][Full Text] [Related]
24. [Physiologic and therapeutic importance of serotonin and the serotonergic system]. Molderings GJ Arzneimittelforschung; 2002; 52(3):145-54. PubMed ID: 11963640 [TBL] [Abstract][Full Text] [Related]
25. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors. Glue PW; Cowen PJ; Nutt DJ; Kolakowska T; Grahame-Smith DG Psychopharmacology (Berl); 1986; 90(3):398-402. PubMed ID: 3097730 [TBL] [Abstract][Full Text] [Related]
26. Effects of serotonin in failing cardiac ventricle: signalling mechanisms and potential therapeutic implications. Levy FO; Qvigstad E; Krobert KA; Skomedal T; Osnes JB Neuropharmacology; 2008 Nov; 55(6):1066-71. PubMed ID: 18675829 [TBL] [Abstract][Full Text] [Related]
27. Modulation of cholinergic functions by serotonin and possible implications in memory: general data and focus on 5-HT(1A) receptors of the medial septum. Jeltsch-David H; Koenig J; Cassel JC Behav Brain Res; 2008 Dec; 195(1):86-97. PubMed ID: 18400315 [TBL] [Abstract][Full Text] [Related]
28. Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. Sharp T; Boothman L; Raley J; Quérée P Trends Pharmacol Sci; 2007 Dec; 28(12):629-36. PubMed ID: 17996955 [TBL] [Abstract][Full Text] [Related]
29. [Mechanism of mediators in human skin. Pharmacoanalysis and therapeutic aspects]. Stüttgen G Hautarzt; 1977 Jun; 28(6):277-85. PubMed ID: 69617 [TBL] [Abstract][Full Text] [Related]
30. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076 [TBL] [Abstract][Full Text] [Related]
36. 5-HT(7) receptors in the modulation of cognitive processes. Cifariello A; Pompili A; Gasbarri A Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350 [TBL] [Abstract][Full Text] [Related]
37. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Meltzer HY; Huang M Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033 [TBL] [Abstract][Full Text] [Related]
39. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders. Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308 [TBL] [Abstract][Full Text] [Related]
40. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]